Johnson & Johnson Pharmaceutical Research & Development L L C Exton, PA - 19341

Johnson & Johnson Pharmaceutical Research & Development L L C is categorized under in Exton, PA .

Johnson & Johnson Pharmaceutical Research & Development L L C was established in 0, and today employs 1 to 4, earning Unknown per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 325412 by the NAICS.

If you are seeking more information, feel free to contact Jason Van Buren at the company’s branch by writing to 665 Stockton Drive # 104, Exton, Pennsylvania PA 19341 or by phoning (610) 458-2192. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Johnson & Johnson Pharmaceutical Research & Development L L C
Contact Person: Jason Van Buren
Address: 665 Stockton Drive # 104, Exton, Pennsylvania 19341
Phone Number: (610) 458-2192
Website Address: oncology.janssenrnd.com
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:

Johnson & Johnson Pharmaceutical Research & Development L L C was started in 0 to provide professional under the SIC code 2834 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Jason Van Buren for inquiries that concern Johnson & Johnson Pharmaceutical Research & Development L L C by calling the company number (610) 458-2192, as your correspondence is most welcome. Additionally, the physical location of the branch of Johnson & Johnson Pharmaceutical Research & Development L L C can be found at the coordinates as well as the street address 665 Stockton Drive # 104 in Exton, Pennsylvania 19341.

For its online presence, you may visit Johnson & Johnson Pharmaceutical Research & Development L L C’s website at oncology.janssenrnd.com and engage with its social media outlets through on Twitter and on Facebook.